Mary Ann Cox - Concepedia

Concepedia

Author

Mary Ann Cox

Boehringer Ingelheim (United States)

Also Known As

Mary A. Cox, Mary A. Cox (663106), Mary Ann Cox

19

Publications

1.1K

Citations

11

H-Index

38

Concepts

All Affiliations

Boehringer Ingelheim (United States)Merck & Co., Inc., Rahway, NJ, USA (United States)AGCO (United Kingdom)Cleveland Clinic University of Pittsburgh

MA

About

Mary Ann Cox is an author at Boehringer Ingelheim (United States) specializing in medicine, pharmacology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	427
2	Biochemistry	2	2	211
3	Engineering	1	1	11
4	Natural Sciences	1	1	180
5	Allergy	1	1	82

Mary Ann Cox

×

12

Publications

1.1K

Citations

11

H-Index

	Year	Citations
Short-chain fatty acids act as antiinﬂammatory mediatorsby regulating prostaglandin E2 and cytokines Mary Ann Cox, James B. Jackson, Michaela C. Stanton, World Journal of Gastroenterology	2009	372
Species-specific antagonism of Ah receptor action by 2,2′,5,5′-tetrachloro- and 2,2′,3,3′,4,4′-hexachlorobiphenyl J.M.M.J.G. Aarts, Michael S. Denison, Mary Ann Cox, European Journal of Pharmacology Environmental Toxicology and Pharmacology Molecular PharmacologyAh Receptor ActionBiochemistryG Protein-coupled ReceptorNatural Sciences	1995	180
Human Interferon-Inducible 10-kDa Protein and Human Interferon-Inducible T Cell α Chemoattractant Are Allotopic Ligands for Human CXCR3: Differential Binding to Receptor States Mary Ann Cox, Chung‐Her Jenh, Waldemar Gonsiorek, Molecular Pharmacology	2001	127
A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection Chung-Her Jenh, Mary Ann Cox, Long Cui, BMC Immunology	2012	82
A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection Chung‐Her Jenh, Mary Ann Cox, Long Cui, BMC Immunology ImmunologyImmunologic MechanismImmunotherapyInflammationCxcr3 Receptor	2012	82
Cutting Edge: Species Specificity of the CC Chemokine 6Ckine Signaling Through the CXC Chemokine Receptor CXCR3: Human 6Ckine Is Not A Ligand for the Human or Mouse CXCR3 Receptors Chung‐Her Jenh, Mary Ann Cox, Meng Zhang, The Journal of Immunology Chemokine BiologyCc ChemokineImmunologyImmunologic MechanismCc Chemokine 6Ckine	1999	70
The pyrimidinergic P2Y6 receptor mediates a novel release of proinflammatory cytokines and chemokines in monocytic cells stimulated with UDP Mary Ann Cox, Benedict A. Gomes, Kyle Palmer, Biochemical and Biophysical Research Communications InflammationMonocytic CellsCytokineSignal TransductionMolecular Physiology	2005	53
Technical Factors Involved in the Measurement of Circulating MicroRNA Biomarkers for the Detection of Colorectal Neoplasia Atsushi Yamada, Mary Ann Cox, Kristin Gaffney, PLoS ONE	2014	48
Ah-receptor mediated luciferase expression: a tool for monitoring dioxin-like toxicity. J.M.M.J.G. Aarts, Michael S. Denison, Laura H.J. de Haan, Socio-Environmental Systems Modeling Molecular PharmacologyBiochemistryMedicineBioanalysisToxicology	1993	31
Human Interferon-Inducible 10-kDa Protein and Human Interferon-Inducible T Cell α Chemoattractant Are Allotopic Ligands for Human CXCR3: Differential Binding to Receptor States Mary Ann Cox, Chung‐Her Jenh, Waldemar Gonsiorek, Molecular Pharmacology	2001	13

Page 1